Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRB | P28702 | 7/20 | 0.64 |
| ▸ | RXRA | P19793 | 6/20 | 0.64 |
| ▸ | RXRG | P48443 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | RARB | P10826 | 2/20 | 0.48 |
| ▸ | RARG | P13631 | 2/20 | 0.48 |
| ▸ | TPMT | P51580 | 1/20 | 0.48 |
| ▸ | RARA | P10276 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5873298 | 0.98 | RXRB (0.62) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| SCHEMBL28170145 | 0.98 | RXRB (0.62) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| SCHEMBL166878 | 0.95 | RXRB (0.59) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4585979 | 0.93 | RXRB (0.57) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL11879619 | 0.93 | RXRB (0.57) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| Water SCHEMBL28383353 | 0.93 | RXRB (0.57) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| SCHEMBL15122888 | 0.91 | RXRB (0.56) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| SCHEMBL12187529 | 0.89 | CES2 (0.57) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| SCHEMBL29419323 | 0.87 | CA12 (0.60) | RXRBRXRARXRGTDP1SMN1; SMN2 | |
| SCHEMBL13043940 | 0.87 | RXRA (0.52) | RXRBRXRARXRGTDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 743 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-110669067-B | Process for preparing alkylalkoxysilanes | 赢创运营有限公司 | 2024-06-04 | — | — | CN | claimed |
| EP-3312214-B1 | METHOD OF SYNTHESISING POLYCARBONATES IN THE PRESENCE OF A BIMETALLIC CATALYST AND A CHAIN TRANSFER AGENT | IMPERIAL INNOVATIONS LTD (GB) | 2023-08-16 | — | — | EP | claimed |
| CN-115710326-A | Dibenzofuran bridged aryloxy metal complex catalyst, and method and application thereof | 万华化学集团股份有限公司 | 2023-02-24 | — | — | CN | claimed |
| CN-108570069-B | Process for preparing tris [3- (alkoxysilyl) propyl ] isocyanurate | 赢创运营有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-108570070-B | Process for preparing tris [3- (alkoxysilyl) propyl ] isocyanurate | 赢创运营有限公司 | 2022-07-05 | — | — | CN | claimed |
| EP-4013438-A1 | HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP | GE Nutrients, Inc. (US) | 2022-06-22 | — | — | EP | claimed |
| CN-114555104-A | Herbal preparation for stimulating hair growth, controlling hair loss, dandruff and infections thereof using ageratum species | GE营养有限公司 | 2022-05-27 | — | — | CN | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-20040242922-A1 | Method of oxidising hydrocarbons to acids | RHODIA POLYMIDE INTERMEDIATES (FR) | 2004-12-02 | — | — | US | claimed |
| CN-1549805-A | Method of oxidising hydrocarbons to acids | ���Ǿ������м��幫˾ | 2004-11-24 | — | — | CN | claimed |
| US-6692880-B2 | FOR PRINTING IMAGES | HEIDELBERGER DRUCKMASCHINEN AG (DE) | 2004-02-17 | — | — | US | claimed |
| US-20030073017-A1 | For printing images | BANK OF AMERICA, N.A., AS AGENT | 2003-04-17 | — | — | US | claimed |
| EP-1293835-A2 | Electrophotographic toner with stable triboelectric properties | Heidelberger Druckmaschinen Aktiengesellschaft (DE) | 2003-03-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | RXRB 407/4885RXRA 577/4885RXRG 570/4885 |
| US-20040242922-A1 | Method of oxidising hydrocarbons to acids | ACOX1, AOC3, ACOX3 | RXRB 445/4885RXRA 573/4885RXRG 669/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | RXRB 1343/4885RXRA 761/4885RXRG 1249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.